Condition

Parkinsonism

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 38 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials38
Recruiting7
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

38 shown
Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PDNCT07674264 · 2026-08-12
RECRUITING
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)NCT07386015 · 2026-02-28
RECRUITING
Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.NCT07207096 · 2025-09-19
RECRUITING
Saliva and Extracellular Vesicles for Neurodegenerative DiseasesNCT06869135 · 2025-01-24
RECRUITING
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesNCT03495024 · 2019-01-01
RECRUITING
Parkinson's Families ProjectNCT02760108 · 2015-04-01
RECRUITING
Modifiable Variables in Parkinsonism (MVP)NCT02194816 · 2012-09-01
RECRUITING
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and ParkinsonismNCT07827963 · 2026-09-01
NOT_YET_RECRUITING
The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease PatientsNCT07442370 · 2026-03-01
COMPLETED
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's DiseaseNCT07176091 · 2025-01-01
ENROLLING_BY_INVITATION
Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's DiseaseNCT05551377 · 2023-01-18
UNKNOWN
Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)NCT05127057 · 2022-10-28
COMPLETED
Biomarkers in Parkinsonian SyndromesNCT06501469 · 2022-03-23
ACTIVE_NOT_RECRUITING
Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia PatientsNCT04929795 · 2021-08-11
COMPLETED
Prodromal and Overt Parkinson's Disease Epidemiological Study in BrazilNCT05677529 · 2021-04-30
UNKNOWN
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System AtrophyNCT04876326 · 2020-10-05
UNKNOWN
Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia PatientsNCT04553835 · 2020-08-31
UNKNOWN
Advance Care Planning and Care Coordination for People With Parkinson's DiseaseNCT05954013 · 2020-08-06
COMPLETED
Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's DiseaseNCT05308485 · 2020-01-06
UNKNOWN
Trial of Parkinson's And Zoledronic AcidNCT03924414 · 2019-11-15
COMPLETED
Study of UB-312 in Healthy Participants and Parkinson's Disease PatientsNCT04075318 · 2019-08-29
COMPLETED
Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic OnsetNCT04086160 · 2019-08-22
UNKNOWN
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismNCT04518059 · 2019-03-12
COMPLETED
Neurology Inpatient Clinical Education TrialNCT03826056 · 2019-02-01
COMPLETED
Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's DiseaseNCT04238000 · 2018-01-01
UNKNOWN
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") DysfunctionNCT03421899 · 2017-08-18
COMPLETED
West Sweden Parkinson Objective Measurement Registry StudyNCT03130595 · 2017-04-26
ACTIVE_NOT_RECRUITING
More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseNCT03076671 · 2017-03-01
COMPLETED
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseNCT03034564 · 2017-01-01
TERMINATED
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's DiseaseNCT03034538 · 2016-04-08
SUSPENDED
Non-motor Symptoms and Brain Dopamine Transporter BindingNCT02650843 · 2015-01-01
ACTIVE_NOT_RECRUITING
Measurement of Gait Using Opal APDM and Gait Mat in ParkinsonismNCT02064543 · 2013-07-01
COMPLETED
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)NCT01888185 · 2012-12-01
COMPLETED
Mobilaser Study to Help With People Who Are Having Problems With Their GaitNCT01581645 · 2012-05-01
COMPLETED
Molecular Analysis of Human Neural Stem CellsNCT01329926 · 2011-06-30
WITHDRAWN
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled BreathNCT01246336 · 2009-08-01
COMPLETED
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian PatientsNCT00767546 · 2009-05-01
UNKNOWN
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and ParkinsonismNCT00745030 · 2008-06-01
TERMINATED

Common interventions

Leading sponsors

Trial status mix

COMPLETED14
UNKNOWN8
RECRUITING7
ACTIVE_NOT_RECRUITING3
TERMINATED2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
SUSPENDED1
WITHDRAWN1

Phase mix

NA14
PHASE44
PHASE12
EARLY_PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.